yogi dewan of hassium asset management is still with us.u have a vaccine, you will get special privileges. a hodgepodge of policy from different countries is what we have seen over the past year. is this part of the reason why you remain underweight europe? and if not that, why? yogi: directly and indirectly, manus. the u.k. of just over 9% and valuations are much more reasonable. the issue in europe is obviously vaccine distribution and rollup. it will have a profound impact on the unemployment rate, which is way behind the u.s. and obviously, it is bound to have an impact on earnings as well. it is earnings that drive share price appreciation, so you've got really negative short-term sentiment around vaccines and unappointed, and a negative medium to longer term sentiment on earnings numbers. the only saving grace is that valuations are more reasonable, and the euro is significantly undervalued versus the u.s. dollar, which should help with an export led recovery longer-term. these are things to look out to later in the year. they are not